Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prognostic Role of Global DNA Methylation in Renal Cancer Reveals Decitabine Treatment Benefit.

Current medicinal chemistry - 1 Jan 2026

Wu Wei, Huang Bin, Xia Peng, Liu Quanzhong, Yi Jin, Zhang Ruohan, Wang Qianghu

Abstract excerpt

BACKGROUND: Renal cancer presents a significant global health challenge due to its rising incidence and mortality rates. Often undetected in early stages, it complicates diagnosis and treatment. Current therapies face resistance and limited effectiveness, especially in advanced stages. The diverse subtypes of renal cancer highlight the need for new biomarkers and risk assessment tools for targeted treatments....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antimetabolites, Antineoplastic
Share to Biomarkers, Tumor

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Decitabine

Share to DNA Methylation

Share to Kidney Neoplasms

Share to Mutation

Share to Prognosis

Source

Identifiers

PMID: 40077820
DOI: 10.2174/0109298673342146250217105350

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prognostic Role of Global DNA Methylation in Renal Cancer Reveals Decitabine Treatment Benefit.PMID 40077820Read ↗

DNA methylation is a key determinant of response to targeted and immune checkpoint therapies in metastatic renal cell carcinomaSemantic proximity Read ↗

Global DNA methylomes reveal oncogenic-associated 5-hydroxylmethylated cytosine (5hmC) signatures in the cell-free DNA of cancer patientsSemantic proximity Read ↗

Genomic DNA Hypomethylation and Risk of Renal Cell Carcinoma: A Case-Control Study.Semantic proximity Read ↗

Molecular Characterization, Clinical Significance, Tumor Microenvironment Association and Drug Susceptibility of DNA Methylation-Driven Genes in Renal Cell CarcinomaSemantic proximity Read ↗

High-throughput methylation sequencing reveals novel biomarkers for the early detection of renal cell carcinomaSemantic proximity Read ↗

Genome-wide DNA methylome analysis identifies methylation signatures associated with survival and drug resistance of ovarian cancersSemantic proximity Read ↗

Development of Gene Expression–Based Score to Predict Sensitivity of Multiple Myeloma Cells to DNA Methylation InhibitorsSemantic proximity Read ↗

A Pan-Cancer Analysis Revealing the Dual Roles of Lysine (K)-Specific Demethylase 6B in Tumorigenesis and ImmunitySemantic proximity Read ↗

Urine DNA methylation assay enables early detection and recurrence monitoring for bladder cancerSemantic proximity Read ↗

DNA Methylation as a Therapeutic Target for Bladder CancerSemantic proximity Read ↗

DNA methylation-based classification and identification of renal cell carcinoma prognosis-subgroupsSemantic proximity Read ↗

Global Epigenetic Profiling In Bladder CancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.